毒品与药物滥用分析

FORENSIC TOXICOLOGY

我们提供新的产品与技术,与您共同努力为各种问题寻求更佳的解决方案。

样品类型(基质)

分析物 MicroSep® 产品 参考文献
尿样 治疗药物⁄滥用药物 对于不同应用,MicroSep® 为您提供装填不同树脂的 DPX tips。如WAX⁄RP(mixed mode)、SCX Journal of Analytical Toxicology
尿样 大麻⁄四氢大麻酚(THC) MicroSep® DPXtips with WAX  Journal of Analytical and Bioanalytical Chemistry
尿样 环苯扎林,阿米替林 MicroSep® DPXtips with RP Journal of Analytical Toxicology
尿液,血液,肝组织,脑组织和胃内容物 苯二氮卓类 MicroSep® DPXtips with WAX Journal of Analytical Toxicology
唾液 治疗药物⁄滥用药物 MicroSep® DPXtips with WAX⁄RP(mixed mode)  
血液⁄血清 大麻 ⁄四氢大麻酚(THC) MicroSep® DPXtips with WAX Journal of Analytical Toxicology  ⁄   Journal of Chromatography AJournal of Chromatography
血液⁄血清 鸦片类药物 MicroSep® ToT Filtration SOFT 2019 Poster Presentation
大麻植物与工业制药原料 大麻 ⁄四氢大麻酚(THC) MicroSep® DPXtips with RP  

 

应用文献

● Rapid Room Temperature Hydrolysis of Glucuronidated Drugs of Abuse using IMCSzyme® RT

● Hydrolysis of sulfated steroids, toxic endobiotics and xenobiotics using purified sulfatase for quantitation of sulfated and unconjugated compounds

● Conversion of drug metabolites due to contaminants in commercialβ-glucuronidase products

● degradation and Conversion of Opioids and Opiates during acid hydrolysis

● The Importance of pH in β-Glucuronidase Hydrolysis Efficiency

● rapid hydrolysis of Glucuronidated opiates and opioids in urine using Imcszyme®

● 使用 IMCSzyme® 在 15 分钟内完成对浓度为 30,000 ng⁄mL 的 6-葡萄糖醛酸代可待因的高效水解

● 《使用 IMCSzyme® 对尿样中海洛因代谢产物 6-单乙酰吗啡的精准定量分析》摘要

● Improving Benzodiazepine Immunoassay Sensitivity by Rapid Glucuronide Hydrolysis Technology

● 《应用 LDTD-MS⁄MS 在 9 秒内完成尿样中抗抑郁药物超快速定量分析》摘要

● 《利用 IMCSzyme® 优化血样中的鸦片类化合物水解及萃取条件》摘要

● 《使用新型重组 β-葡萄糖醛酸酶对丁丙诺啡的水解效率分析》摘要

● 《尿样中氟哌啶醇及其代谢产物的酶解及分析》摘要

● 《利用新型重组 β-葡萄糖醛酸酶对尿样中的纳洛酮进行水解及 LC-MS/MS 分析》摘要

● 《利用新型重组 β-葡萄糖醛酸酶进行尿样中的鸦片类药品的水解及定量分析》摘要

● A summary of “Screening and Quantification of Pain and Antidepressant Drugs in Human Urine by Liquid Chromatography-High Resolution Mass Spectrometry”

● A summary of “Rapid Enzyme Hydrolysis Using a Novel Recombinant β-Glucuronidase in Benzodiazepine Urine Analysis”

● A summary of “Meconium Targeted Drug Screening in 9 seconds per Sample Using Laser Diode Thermal Desorption Mass Spectrometry (LDTD-MS⁄MS)”

● A summary of “LC-MS/MS Method for the Determination of Tricyclic and Tetracyclic Antidepressants in Human Urine”

● A summary of “Hydrolyze Your Way to Compliance – A Call for Pain Management Certified Reference Materials”

● A summary of “Isomer interferences observed during the development of a 47-analyte HRAM LC-MS⁄MS method for urine drug testing”

● A summary of “Fast Simple, and Accurate Method for Urine Drugs of Abuse Screening and Quantitation Using Liquid Chromatography with Time of Flight (TOF) Mass”

● A summary of “Comparison of Novelβ-Glucuronidases for Process Improvement in Urine Toxicology Workflows”

● A summary of “Uromics: Metabolomics in Urine for Seroquel®, Latuda®, and Haldol®”

期刊文献

● Application of High-Resolution UPLC–MSE/TOF Confirmation in Forensic Urine Drug Screening by UPLC–MS/MS

Rosano TG, Ohouo PY, Wood M.
Journal of Analytical Toxicology; 43(5):353-63. doi: 10.1093/jat/bky106

● Stability and Hydrolysis of Desomorphine-Glucuronide.?Journal of Analytical Toxicology.

Winborn J, Kerrigan S.
Journal of Analytical Toxicology; doi: 10.1093/jat/bkz021.

● Characterization of an Amphetamine Interference from Gabapentin in an LC–HRMS Method.

Muñoz-Muñoz AC, Pekol T, Schubring D, Hyland R, Johnson C, Andrade L.
Journal of Analytical Toxicology; doi: doi: 10.1093/jat/bkz046.

● Identification of Novel Opioid Interferences using High-Resolution Mass Spectrometry.

Muñoz-Muñoz AC, Pekol T, Schubring D, Johnson C, Andrade L.ccess
Journal of Analytical Toxicology; 42(1):6-16. doi: 10.1093/jat/bkx065.

● Impact of β-Glucuronidase Mediated Hydrolysis on Haldol® Urinalysis.

Cummings OT, Strickland EC, Enders JR, McIntire GL.
Journal of Analytical Toxicology; 42(4):214-219. doi: 10.1093/jat/bkx103.

● Zolpidem and Zolpidem Carboxylic Acid Results from Medication Monitoring.

Feng S, Cummings OT, McIntire G.
Journal of Analytical Toxicology; 42(7):491-5. doi: 10.1093/jat/bky033.

● Systematic Evaluation and Validation of Benzodiazepines Confirmation Assay Using LC-MS-MS.

Kang MG, Lin HR.
Journal of Analytical Toxicology; 43(2):96-103. doi: 10.1093/jat/bky071.

● Development and Validation of a Novel All-Inclusive LC–MS-MS Designer Drug Method.

Strickland EC, Cummings OT, McIntire GL, Mellinger AL.
Journal of Analytical Toxicology; 43(3):161-9. doi: 10.1093/jat/bky087.

● Comparison of Purified β-glucuronidases in Patient Urine Samples Indicates a Lack of Correlation Between Enzyme Activity and Drugs of Abuse Metabolite Hydrolysis Efficiencies Leading to Potential False Negatives.

Sitasuwan P, Melendez C, Marinova M, Spruill M, Lee LA.
Journal of Analytical Toxicology; 43(3):221-227. doi: 10.1093/jat/bky082

● Impact of enzymatic hydrolysis on the quantification of total urinary concentrations of chemical biomarkers.

Dwivedi P, Zhou X, Powell TG, Calafat AM, Ye X.
Chemosphere; 199:256-62. doi: 10.1016/j.chemosphere.2018.01.177.

● Opiate & Benzodiazepine Confirmations: To Hydrolyze or Not to Hydrolyze is the Question.

Johnson-Davis KL.
Journal of Applied Laboratory Medicine; 2(4):564. doi: 10.1373/jalm.2016.022947. Review Article.

● Internal Hydrolysis Indicator for Sample Specific Monitoring of β-Glucuronidase Activity.

Taylor LL, Flint NA, Ma V, Hill BM, Clark CJ, Strathmann FG.
Journal of Analytical Toxicology;41(5):407-411. doi: 10.1093/jat/bkx027.

● Screening with Quantification for 64 Drugs and Metabolites in Human Urine using UPLC–MS-MS Analysis and a Threshold Accurate Calibration.

Rosano TG, Ohouo PY, Wood M.
Journal of Analytical Toxicology;41(6):536-46. doi: 10.1093/jat/bkx035.

● Development and Validation of a Novel LC-MS/MS Opioid Confirmation Assay: Evaluation of β-glucuronidase Enzymes and Sample Cleanup Methods.

Yang HS, Wu AH, Lynch KL.
Journal of Analytical Toxicology;40(5):323-329. doi: 10.1093/jat/bkw026.

● Degradation of Opioids and Opiates During Acid Hydrolysis Leads to Reduced Recovery Compared to Enzymatic Hydrolysis.

Sitasuwan P, Melendez C, Marinova M, Mastrianni K, Darragh A, Ryan E, Lee LA.
Journal of Analytical Toxicology;40(8):601-607. doi: 10.1093/jat/bkw085.

● Definitive Drug and Metabolite Screening in Urine by UPLC–MS-MS Using a Novel Calibration Technique.

Rosano TG, Ohouo PY, LeQue JJ, Freeto SM, Wood M.
Journal of Analytical Toxicology;40(8):628-38. doi: 10.1093/jat/bkw050.

● Variations in enzymatic hydrolysis efficiencies for amitriptyline and cyclobenzaprine in urine.

Mastrianni KR, Lee LA, Brewer WE, Dongari N, Barna M, Morgan SL.
Journal of Analytical Toxicology;40:732-737. doi: 10.1093/jat/bkw062.

● Rapid Enzymatic Hydrolysis Using a Novel Recombinant β-Glucuronidase in Benzodiazepine Urinalysis.

Morris AA, Chester SA, Strickland EC, McIntire GL.
Journal of Analytical Toxicology;38(8):610-614. doi: 10.1093/jat/bku083.

● Comprehensive Analysis of Drugs of Abuse in Urine Using Disposable Pipette Extraction

Sparkle T. Ellison,William E. Brewer,Stephen L. Morgan
doi: 10.1093/jat/33.7.356.

● Simultaneous quantification of 11 cannabinoids and metabolites in human urine by liquid chromatography tandem mass spectrometry using WAX-S tips

Maria Andersson, Karl B. Scheidweiler, Cristina Sempio, Allan J. Barnes & Marilyn A. Huestis
doi: 10.1007/s00216-016-9765-8.

● Quantification of cannabinoids and their free and glucuronide metabolites in whole blood by disposable pipette extraction and liquid chromatography-tandem mass spectrometry

Karl B. Scheidweiler,Matthew N.Newmeyer,Allan J.Barnes,Marilyn A.Huestis
doi: 10.1016/j.chroma.2016.05.024.

● Ultra Performance Liquid Chromatography with Tandem Mass Spectrometry for the Quantitation of Seventeen Sedative Hypnotics in Six Common Toxicological Matrices.

Dani C. Mata, John F. Davis, Ariana K. Figueroa, Mary June Stanford
doi: 10.1093/jat/bkv111.

 

  • toolbar
    17715681752
  • toolbar
    toolbar
  • toolbar
  • toolbar